JC
JCR Pharmaceuticals Co., Ltd.
JCRRF · OTC
$3.33 +0.00% (+$0.00)
Market Cap ¥63.9B
P/E Ratio 73.87x
Div. Yield 3.92%
ROE 2.53%
Bulios Fair Price
$2.2
33.9% downside
Current Price
$3.33
Undervalued Fair Value Overvalued
According to Bulios Fair Price, JCRRF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
5/9Valuation
30 /100
Expensive P/B 1.49x
P/S 1.54x
P/E 73.87x
Growth
3 /100
Declining Book val. growth 2.58%
Rev. growth 13.49%
FCF growth N/A
Profitability
26 /100
Weak FCF margin 0.00%
Op. margin 2.33%
Gross margin 75.62%
Quality
10 /100
Poor Asset turnover 0.39x
ROA 0.82%
ROIC 0.46%
Debt
29 /100
High Net debt/EBITDA 10.53x
Int. coverage 3.84x
Debt/Equity 1.25x
Stability
30 /100
Unstable Profitable years 0
EPS volatility 116.43%
Beta 0.53x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about JCRRF
Online
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Toru Ashida
Employees
985
Headquarters
Ashiya
Upcoming events
29 SEP
Ex-Dividend
Ex-dividend date
29 SEP
Dividend Payment
Payment date
28 OCT
Earnings
Upcoming earnings report
30 MAR
Ex-Dividend
Ex-dividend date
30 MAR
Dividend Payment
Payment date